AIT Value & Performance Lead
Pfizer
AIT Value & Performance Lead
Pfizer
Makes cancer drugs, vaccines and other medicines
1. Role Summary
The AIT Value & Performance Lead owns the value case for Pfizer China’s AI portfolio — business cases, KPIs and benefits realization, with model-cost as a core value lever. The role converts market insights into Build-Buy-Partner and AI investment decisions, and identifies globally reusable China capabilities, framing the value case and prioritizing productization investment.
Working across the AITO acceleration and portfolio teams, the role provides the economic discipline and performance transparency that guide what AI is worth doing, at what cost, and where China-for-Global reuse creates the most value.
2. Key Accountabilities
3. Required Capabilities & Competencies
(a) Critical Capabilities & Qualifications
(b) Leadership Expectations
4. Key Collaboration
The role partners with the AIT Acceleration Lead, AI product owners and the AIT Portfolio PMO within AITO, under the AITO Head, and works closely with Go-to-Market Transformation (GTMx) on Build-Buy-Partner and investment decisions. It partners with Global Commercial Analytics (GCA) and China Business Units for market insight and value validation, and with Finance and Procurement on investment and cost. It also engages International AIT to frame the value case for globally reusable China capabilities.
5. Measures of Success
Pfizer is an equal opportunity employer and complies with all applicable equal employment opportunity legislation in each jurisdiction in which it operates.
To learn more about acceptable and prohibited uses of AI during the recruitment process, please review our candidate AI-use guidelines available on Pfizer Careers.
Information & Business TechPfizer discovers, makes, and sells prescription medicines and vaccines for patients, doctors, and governments worldwide, with large businesses in vaccines, cancer, heart disease, and rare diseases. In 2020, its COVID-19 shot, developed with German partner BioNTech, became the first COVID-19 vaccine authorized in the United States. Its scientists find drug candidates and run clinical trials to prove they are safe and effective, and Pfizer then manufactures approved products in its own plants, earning most of its money from patented drugs before cheaper generic copies arrive. Pfizer was founded in 1849 as a chemicals business in Brooklyn and is based in New York City.
Explore more opportunities at Pfizer